BRANDON GREGORY TWOMBLY

Allopathic & Osteopathic Physicians|Family Medicine BRYN MAWR, PA NPI 1013595396

General Payments — all program years on this page

$783.35

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $719.65 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $719.6521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $63.702
2024 $719.6521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078146467 Janssen Pharmaceuticals, Inc $24.22 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097799343 Novo Nordisk Inc $21.16 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097823708 Novo Nordisk Inc $22.16 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104283599 AstraZeneca Pharmaceuticals LP $15.07 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105631479 AstraZeneca Pharmaceuticals LP $17.38 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105904843 VERTEX PHARMACEUTICALS INCORPORATED $18.82 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106255817 ABBVIE INC. $14.00 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106255819 ABBVIE INC. $16.70 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106255821 ABBVIE INC. $23.51 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110734127 Eisai Inc. $31.75 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114461346 Exact Sciences Corporation $20.66 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134567597 Helsinn Therapeutics (U.S.), Inc. $23.29 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136073633 Lilly USA, LLC $18.04 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136073635 Lilly USA, LLC $20.32 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140004876 SANOFI-AVENTIS U.S. LLC $31.80 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143335753 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.43 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150150287 SHIELD THERAPEUTICS INC $55.82 10/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151134894 Phathom Pharmaceuticals, Inc. $14.89 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152130514 SUN PHARMACEUTICAL INDUSTRIES INC. $138.37 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152130516 SUN PHARMACEUTICAL INDUSTRIES INC. $137.61 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154052291 iRhythm Technologies, Inc. $33.65 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.